trihexyphenidyl has been researched along with Glomerulonephritis, Membranous in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ratovo, L | 1 |
| Bérard, E | 1 |
| Khaida, J | 1 |
| Moupoux, F | 1 |
| Cassuto-Viguier, E | 1 |
| Mariani, R | 1 |
1 other study available for trihexyphenidyl and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
[Sharp syndrome in an infant: a case report].
Topics: Child; Glomerulonephritis, Membranous; Haloperidol; Humans; Male; Methylprednisolone; Mixed Connecti | 1992 |